These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1678866)

  • 21. Bidirectional modulation of GABA function by beta-carbolines.
    Jensen LH; Petersen EN; Honoré T; Drejer J
    Adv Biochem Psychopharmacol; 1986; 41():79-89. PubMed ID: 2874696
    [No Abstract]   [Full Text] [Related]  

  • 22. Behavioral pharmacology of the benzodiazepines.
    Neurosci Biobehav Rev; 1985; 9(1):1-151. PubMed ID: 2858073
    [No Abstract]   [Full Text] [Related]  

  • 23. Behavioral studies with anxiolytic drugs. II. Interactions of zopiclone with ethyl-beta-carboline-3-carboxylate and Ro 15-1788 in squirrel monkeys.
    Barrett JE; Brady LS; Stanley JA; Mansbach RS; Witkin JM
    J Pharmacol Exp Ther; 1986 Feb; 236(2):313-9. PubMed ID: 2868115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of lorazepam on CNS structures: neurophysiological and behavioral correlations.
    Figueroa RG; Figueroa EG; Sneed GA; Kennedy MJ
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):137-46. PubMed ID: 4156666
    [No Abstract]   [Full Text] [Related]  

  • 25. Benzodiazepine-like behavioral effects following withdrawal from chronic delta-9-tetrahydrocannabinol administration in rats.
    Holson RR; Ali SF; Scallet AC; Slikker W; Paule MG
    Neurotoxicology; 1989; 10(3):605-19. PubMed ID: 2576305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abecarnil is a full agonist at some, and a partial agonist at other recombinant GABAA receptor subtypes.
    Pribilla I; Neuhaus R; Huba R; Hillmann M; Turner JD; Stephens DN; Schneider HH
    Psychopharmacol Ser; 1993; 11():50-61. PubMed ID: 7908433
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacokinetics and acute toleration of the beta-carboline derivative abecarnil in man.
    Krause W; Schütt B; Duka T
    Arzneimittelforschung; 1990 May; 40(5):529-32. PubMed ID: 1974428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experimental studies in guinea pigs of the behavioral and electrocardiographic effects of bromazepam. Clinical research on its use in the treatment of some psychosomatic syndromes].
    Bianchi A; De Marino V; Baiano G
    Clin Ter; 1975 Jun; 73(5):441-59. PubMed ID: 237649
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of anxiolytic drugs on some behavioral consequences in olfactory bulbectomized rats.
    Wierońska JM; Papp M; Pilc A
    Pol J Pharmacol; 2001; 53(5):517-25. PubMed ID: 11990071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neurochemical and behavioral study on the mechanism of the antidepressant and anxiolytic effect of co-administration of lithium and monoamine oxidase inhibitors].
    Kitaichi Y
    Hokkaido Igaku Zasshi; 2004 Jan; 79(1):93-101. PubMed ID: 14978979
    [No Abstract]   [Full Text] [Related]  

  • 31. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anxiolytic action of beta-carbolines in rats].
    Burov IuV; Orekhov SN; Vedernikova NN
    Biull Eksp Biol Med; 1985 Apr; 99(4):453-5. PubMed ID: 2859060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some behavioral effects of chlorodesmethyldiazepam and lorazepam.
    Kostowski W; Płaźnik A; Puciłowski O; Trzaskowska E; Lipińska T
    Pol J Pharmacol Pharm; 1981; 33(6):597-602. PubMed ID: 6127668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The behavioral characteristics of young and sexually mature animals administered fenazepam, gidazepam and medazepam].
    Voronina TA; Molodavkin GM; Ramkhin EIa
    Eksp Klin Farmakol; 1993; 56(3):3-5. PubMed ID: 8106053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated plus-maze: a novel psychobehavioral tool to measure anxiety in rodents.
    Kulkarni SK; Sharma AC
    Methods Find Exp Clin Pharmacol; 1991 Oct; 13(8):573-7. PubMed ID: 1683415
    [No Abstract]   [Full Text] [Related]  

  • 36. Proceedings: Effect of oxypertine on anxiety-induced behaviour in baboons.
    Beattie IA; Berry PA; Lister RE
    Br J Pharmacol; 1972 Feb; 44(2):348P-349P. PubMed ID: 4203347
    [No Abstract]   [Full Text] [Related]  

  • 37. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abecarnil, a new beta-carboline, in the treatment of anxiety disorders.
    Aufdembrinke B
    Br J Psychiatry Suppl; 1998; (34):55-63. PubMed ID: 9829018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons.
    Giffiths RR; Sannerud CA; Lamb RJ; Ator NA; Brady JV
    NIDA Res Monogr; 1990; 105():329. PubMed ID: 1678867
    [No Abstract]   [Full Text] [Related]  

  • 40. Behavioral neurochemistry of benzodiazepines.
    Stein L
    Arzneimittelforschung; 1980; 30(5a):868-73. PubMed ID: 6106487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.